Wang W,Zuo B,Liu H,Cui L H .2019 .Intermittent injection of methylprednisolone sodium succinate in the treatment of cervical spinal cord injury complicated with incomplete paraplegia. Pak J Med Sci, 10(1) : 141-5.
Ding W,Hu S,Wang P,Kang H,Peng R,Dong Y .2022 .Spinal cord injury: The global incidence, prevalence, and disability from the global burden of disease study 2019. Spine (Phila Pa, 10(21) : 1532-40.
Yu M,Wang Z,Wang D,Aierxi M,Wang Z,Y Z .2023 .Oxidative stress following spinal cord injury: From molecular mechanisms to therapeutic targets. J Neurosci Res, 10(10) : 1538-54.
Liu YX,Liu Q,Deng R .2018 .Curativc e ect of monosialoganglioside GM1 on postoperative cognitive dysfunction in the patients with craniocerebral trauma: A metaanalysis. Hainan Med J, 29(9) : 1311-5.
Shijie Zhang .2008 .Clinical spinal surgery. , : 66-68.
Liu Z,Yao X,Jiang W,Li W,Zhu S,Liao C . .Advanced oxidation protein products induce microglia-mediated neuroin ammation via MAPKs-NF-ºB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuro-, : .
Kirshblum S,Snider B,Eren F,Guest J .2020 .Characterising natural recovery after traumatic spinal cord injuryJ. Neurotrauma, 7473(9) : 1267-84.
Hu X,Xu W,Ren Y,Wang Z,He X,Huang R .2023 .Spinal cord injury: Molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther, 10(1) : 245.
Guo S,Redenski I,Levenberg S. .1872 .Spinal cord repair: From cells and tissue engineering to extracellular vesicles. Cells, 10(8) : .
Sterner RC,Sterner RM .2022 .Immune response following traumatic spinal cord injury: Pathophysiology and therapies. Front Immunol, 1084101 : 1084101.
Yao X,Sun C,Fan B,Zhao C,Zhang Y,Duan H .2020 .Neurotropin exerts neuroprotective e ects after spinal cord injury by inhibiting apoptosis and modulating cytokines. J Orthop Translat, 02 : 74-83.
Choi SH,Sung CH,Heo DR,Jeong SY,Kang CN .2020 .Incidence of acute spinal cord injury and associated complications of methylprednisolone therapy: A national population-based study in South Korea. Spinal Cord, 10(2) : 232-7.
Guha L,Kumar H .2023 .Drug repurposing for spinal cord injury: Progress towards therapeutic intervention for primary factors and secondary complications. Pharmaceut Med, 10(6) : 463-90.
Guo Z. Ganglioside .2023 .GM1 and the central nervous system. Int J Mol Sci, 10(11) : 9558.
Chiricozzi E,Lunghi G,Di Biase E,Fazzari M,Sonnino S .2020 .GM1 ganglioside is a key factor in maintaining the mammalian neuronal functions avoiding neurodegeneration. Int J Mol Sci, 10(3) : 868.
Jiang X,Liu X,Yu Q,Shen W,Mei X,Tian H .2021 .Functional resveratrol-biodegradable manganese doped silica nanoparticles for the spinal cord injury treatment. Mater Today Bio, 100177 : 100177.
Liu Z,Tu K,Zou P,Liao C,Ding R,Huang Z .2023 .Hesperetin ameliorates spinal cord injury by inhibiting NLRP3 in ammasome activation and pyroptosis through enhancing Nrf2 signaling. Int Immunopharmacol, 110103 : 110103.